NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,802.70+₹41.70 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · ZENITHDRUG.NS · INR
Stock price, dividends
Quote as of Oct 30, 2026, 05:46 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Zenith Drugs Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.82% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Zenith Drugs Ltd. engages in the manufacture and trade of medicines. It offers a wide range of formulations in various forms such as ORS powder, liquid orals, ointments, liquid externals, and capsules. The company was founded by Shri Ramniklal T. Soni and Mr. Mukesh Jain on November 15, 2000 and is headquartered in Indore, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹1,802.70+₹41.70 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,733.00+₹69.00 (+0.71%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹4,629.20+₹49.20 (+1.07%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.82% below the high.
₹2,362.60+₹118.60 (+5.29%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.8% below the high.
₹1,235.80+₹51.40 (+4.34%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 1.11% below the high.
₹8,328.50+₹128.50 (+1.57%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 8.41% below the high.
₹681.05-₹0.70 (-0.1%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
₹1,355.50+₹10.50 (+0.78%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.18% below the high.
